Lv11
100 积分 2024-05-22 加入
The fibrogenic niche in kidney fibrosis: components and mechanisms
4个月前
已完结
Advances and challenges in kidney fibrosis therapeutics
4个月前
已完结
Gallic acid and loganic acid attenuate amyloid-β oligomer-induced microglia damage via NF-КB signaling pathway
6个月前
已完结
Emerging diagnostics and therapeutics for Alzheimer disease
7个月前
已完结
Targeting the gut and tumor microbiota in cancer
8个月前
已完结
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
8个月前
已完结
High-throughput identification of gut microbiome-dependent metabolites
8个月前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
10个月前
已完结
PCSK9 inhibitors: clinical evidence and implementation
10个月前
已完结
Inhibiting PCSK9 — biology beyond LDL control
10个月前
已完结
皖公网安备34019202002308
